Profilo
Reinilde Heyrman is currently Chief Medical Officer at Medpace Holdings, Inc. since 2017.
Former positions include Chief Clinical Development Officer at Ikaria, Inc. and Secretary, Chief Clinical Development Officer & VP at Bellerophon Therapeutics, Inc. Education includes a doctorate from the University of Antwerp.
Posizioni attive di Reinilde Heyrman
| Società | Posizione | Inizio |
|---|---|---|
| MEDPACE HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2017 |
Precedenti posizioni note di Reinilde Heyrman
| Società | Posizione | Fine |
|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | - |
| BELLEROPHON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Reinilde Heyrman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Ikaria, Inc.
Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Holdings, Inc.
Medpace Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a a clinical contract research organization company which provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries | Commercial Services |
















